Table 3.

SARS-CoV-2 Testing Platform Prioritization Matrix for Patient Testing^a

	Patient Population
	Symptomatic: Rule out COVID-19	Symptomatic: Prior COVID-19 Negative	Asymptomatic: Inpatient Admission	Asymptomatic: Preadmission
TAT Requirement (h)	1	1-12	1-12	24-72
Consequences of incorrect test	Lower, patient kept in isolation due to high clinical index of suspicion	High, patient may be removed from isolation due to negative test result	High, exposure risk to others	High, exposure risk to others
Assay-based method	POCT	Rapid RT-PCR	Rapid RT-PCR	Batched RT-PCR

COVID-19, coronavirus disease 2019; POCT, point-of-care test; RT-PCR, reverse transcription polymerase chain reaction; TAT, turnaround time.

^aDepending on the presentation of patients and the TAT requirement, the matrix uses each available platform based on the patient population.